Cargando…

Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm Morphotypes

Achromobacter species have attracted attention as emerging pathogens in cystic fibrosis. The clinical significance of Achromobacter infection is not yet fully elucidated; however, their intrinsic resistance to antimicrobials and ability to form biofilms renders them capable of establishing long-term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielsen, Signe M., Nørskov-Lauritsen, Niels, Bjarnsholt, Thomas, Meyer, Rikke L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039593/ https://www.ncbi.nlm.nih.gov/pubmed/27681927 http://dx.doi.org/10.3390/microorganisms4030033

Ejemplares similares

Differences in Gene Expression Profiles between Early and Late Isolates in Monospecies Achromobacter Biofilm
por: Nielsen, Signe M., et al.
Publicado: (2017)

Genetic Adaptation of Achromobacter sp. during Persistence in the Lungs of Cystic Fibrosis Patients
por: Ridderberg, Winnie, et al.
Publicado: (2015)

Motility, Biofilm Formation and Antimicrobial Efflux of Sessile and Planktonic Cells of Achromobacter xylosoxidans
por: Nielsen, Signe M., et al.
Publicado: (2019)

Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

Achromobacter spp. genetic adaptation in cystic fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

Induction of Broad β-lactam Resistance in Achromobacter ruhlandii by Exposure to Ticarcillin Is Primarily Linked to Substitutions in Murein Peptide Ligase Mpl
por: Andersen, Camilla, et al.
Publicado: (2022)

Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis
por: Chalhoub, Hussein, et al.
Publicado: (2022)

Antibiotic susceptibility of cystic fibrosis lung microbiome members in a multispecies biofilm
por: Vandeplassche, Eva, et al.
Publicado: (2020)

Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients
por: Veschetti, Laura, et al.
Publicado: (2021)

Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis
por: Tetart, Macha, et al.
Publicado: (2019)

Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains
por: Trancassini, Maria, et al.
Publicado: (2014)

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
por: Lambiase, A., et al.
Publicado: (2011)

Exoproducts of the Most Common Achromobacter Species in Cystic Fibrosis Evoke Similar Inflammatory Responses In Vitro
por: Sahl, Cecilia, et al.
Publicado: (2023)

Whole Genome Sequencing of Aggregatibacter actinomycetemcomitans Cultured from Blood Stream Infections Reveals Three Major Phylogenetic Groups Including a Novel Lineage Expressing Serotype a Membrane O Polysaccharide
por: Nedergaard, Signe, et al.
Publicado: (2019)

Draft Genome Sequence of Triclosan-Resistant Cystic Fibrosis Isolate Achromobacter xylosoxidans CF304
por: Jeukens, Julie, et al.
Publicado: (2015)

Complete Genome Sequence of Achromobacter xylosoxidans MN001, a Cystic Fibrosis Airway Isolate
por: Badalamenti, Jonathan P., et al.
Publicado: (2015)

Draft genome sequences of four Achromobacter ruhlandii strains isolated from cystic fibrosis patients
por: Rodrigues, Elenice RA, et al.
Publicado: (2016)

Complete Genome Sequence of the Cystic Fibrosis Pathogen Achromobacter xylosoxidans NH44784-1996 Complies with Important Pathogenic Phenotypes
por: Jakobsen, Tim Holm, et al.
Publicado: (2013)

Multilocus Sequence Typing of Aggregatibacter actinomycetemcomitans Competently Depicts the Population Structure of the Species
por: Nedergaard, Signe, et al.
Publicado: (2021)

VEB-1 in Achromobacter xylosoxidans from Cystic Fibrosis Patient, France
por: Neuwirth, Catherine, et al.
Publicado: (2006)

Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
por: Firmida, M.C., et al.
Publicado: (2016)

Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection
por: Veschetti, Laura, et al.
Publicado: (2020)

Mobilome Analysis of Achromobacter spp. Isolates from Chronic and Occasional Lung Infection in Cystic Fibrosis Patients
por: Veschetti, Laura, et al.
Publicado: (2021)

In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics
por: Sandri, Angela, et al.
Publicado: (2023)

Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports
por: Firmida, Mônica Cássia, et al.
Publicado: (2017)

Achromobacter spp. Adaptation in Cystic Fibrosis Infection and Candidate Biomarkers of Antimicrobial Resistance
por: Sandri, Angela, et al.
Publicado: (2022)

In Vitro Activity of 22 Antibiotics against Achromobacter Isolates from People with Cystic Fibrosis. Are There New Therapeutic Options?
por: Beauruelle, Clémence, et al.
Publicado: (2021)

Candida parapsilosis Colony Morphotype Forecasts Biofilm Formation of Clinical Isolates
por: Gómez-Molero, Emilia, et al.
Publicado: (2021)

Sepsis Caused by Achromobacter Xylosoxidans in a Child with Cystic Fibrosis and Severe Lung Disease
por: Stobbelaar, Kim, et al.
Publicado: (2016)

Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature
por: Cools, Piet, et al.
Publicado: (2016)

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
por: Marsac, Charlotte, et al.
Publicado: (2021)

Characterization of the Achromobacter xylosoxidans Type VI Secretion System and Its Implication in Cystic Fibrosis
por: Le Goff, Mélanie, et al.
Publicado: (2022)

730. Cefiderocol for the Treatment of Achromobacter xylosoxidans Infections in Two Lung Transplant Patients with Cystic Fibrosis
por: Warner, Nathaniel C, et al.
Publicado: (2019)

Adaptive Interactions of Achromobacter spp. with Pseudomonas aeruginosa in Cystic Fibrosis Chronic Lung Co-Infection
por: Sandri, Angela, et al.
Publicado: (2021)

Genomic and Phenotypic Evolution of Achromobacter xylosoxidans during Chronic Airway Infections of Patients with Cystic Fibrosis
por: Khademi, S. M. Hossein, et al.
Publicado: (2021)

Genome Sequence of Staphylococcus epidermidis AUH4567, a Clinical Isolate from an Infected Central Venous Catheter
por: Meyer, Rikke Louise, et al.
Publicado: (2021)

Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients’ Lung
por: Menetrey, Quentin, et al.
Publicado: (2021)

Pseudobacteremia outbreak of biofilm-forming Achromobacter xylosoxidans – environmental transmission
por: Günther, Frank, et al.
Publicado: (2016)

Into the well—A close look at the complex structures of a microtiter biofilm and the crystal violet assay
por: Kragh, Kasper Nørskov, et al.
Publicado: (2019)

High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis
por: Menetrey, Quentin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_863bbuh7a6pg2ctgc4s7lljqqp